General
Preferred name
GW4064
Synonyms
GW 4064 ()
P&D ID
PD010576
CAS
278779-30-9
1089660-72-9
Tags
available
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Orally active liver X receptor (LXR) agonist (Tocris Bioactive Compound Library)
DESCRIPTION Selective farnesoid X receptor (FXR) agonist (Tocriscreen Total)
DESCRIPTION GW4064 is a selective non-steroidal agonist of farnesoid X receptor (FXR) with EC50 value of 15 nM. (BOC Sciences Bioactive Compounds)
Compound Sets
21
AdooQ Bioactive Compound Library
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
EU-OPENSCREEN Bioactive Compound Library
EUbOPEN Chemogenomics Library
Guide to Pharmacology
Mcule NIBR MoA Box Subset
MedChem Express Bioactive Compound Library
Novartis Chemogenetic Library (NIBR MoA Box)
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Tocris Bioactive Compound Library
Tocriscreen Total
External IDs
26
Properties
(calculated by RDKit )
Molecular Weight
541.06
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
1
Rotatable Bonds
8
Ring Count
4
Aromatic Ring Count
4
cLogP
8.87
TPSA
72.56
Fraction CSP3
0.14
Chiral centers
0.0
Largest ring
6.0
QED
0.23
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Metabolism
Autophagy
Metabolic Enzyme/Protease
Target
FXR
NR1H4
Autophagy,FXR
Primary Target
LXR-like Receptors
MOA
Agonist
Farnesoid X Receptor (FXR) Agonists
FXR agonist
Member status
member
Recommended Cell Concentration
None
Source data